Beverly MK Biller, MD is an endocrinologist in the Massachusetts General Hospital (MGH) Neuroendocrine Clinical Center. She is a faculty member in the Neuroendocrine Unit at MGH and a Professor of Medicine at Harvard Medical School. Dr. Biller's major clinical and research interests include the diagnosis and treatment of Cushing's disease, prolactinomas, acromegaly, other pituitary tumors and sellar masses, and pituitary hormone deficiencies in adults.
ResearchDr. Biller is a clinical investigator who focuses on pituitary disorders. Major research interests include the diagnosis and treatment of Cushing's disease, prolactinomas, acromegaly, other pituitary tumors and sellar masses as well as pituitary hormone deficiencies, including growth hormone deficiency in adults.
Fleseriu et al Mifepristone, a glucocorticoid receptor antagonist.... J Clin Endocrinol Metab. 2012 Jun;97(6):2039
Colao et al A 12-month phase III study of pasireotide in Cushing?s disease. N Engl J Med. 2012; 366:914
Biller et al 12-Month effects of once-weekly sustained-release growth hormone treatment... Pituitary. 2012 Aug 23
Bertagna et al LCI699, a potent 11?-hydroxylase inhibitor, normalizes urinary cortisol ... J Clin Endocrinol Metab. 2013 Dec 10
A new investigational drug significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of this endocrine disorder ever conducted.